Biotech Stocks

U.S. Exchanges

Biotech Stocks

A list of publicly traded biotech companies can be found by scrolling down or you can access a list of the companies in each group through the industry links on this page.

There are hundreds of publicly traded biotech companies on U.S. exchanges and to help our visitors navigate this large group of companies we have organized our biotech section into two primary categories: market capitalization and specific areas of focus.

Large, Mid, Small, Micro and Nano-Cap Biotech Sections: Each of these sections is comprised of stocks based on market capitalization:

Large-Cap Biotech: These stocks have a market capitalization over ten billion dollars.

Mid-Cap Biotech: These stocks have a market capitalization between two and ten billion dollars.

Small-Cap Biotech: These stocks have a market capitalization between 300 million and two billion dollars.

Micro-Cap Biotech: These stocks have a market capitalization between 50 million and 300 million dollars.

Nano-Cap Biotech: These stocks have a market capitalization under 50 million dollars.

We update this page at the start of every month so it is possible that during the course of a month a stock’s market cap might fall below or go above these capitalization levels.

Healthcare Focus Areas: In these sections you will find medical device, biotech, pharmaceutical or other healthcare companies that provide drugs, equipment, products, services or therapeutics in a number of different categories including:

Specific/Classes of Diseases: Cancer, Diabetes, Infectious Diseases, Multiple Sclerosis, Neurological, and Rare Diseases.

Areas of the Body: Blood, Central Nervous System, Dental, Ears, ENT, Eye Care, Gastrointestinal, Heart, Kidney, Liver, Respiratory Health, Skin Care, Spine, Urology and Vascular.

Specific Demographics: Animal Health, Children and Women’s Health.

You will also find a number of other specialty categories including:

Aesthetics

Pain Management

Sleep

Weight Loss

Wound Care

While there are certainly other healthcare companies in these sections, a large percentage of a number of these categories are comprised of biotech companies.

Related Links:

List of Healthcare Companies

List of Pharmaceutical Companies

List of Healthcare Facilities

List of Medical Device Companies

List of Publicly Traded Companies




List of Publicly Traded Biotech Companies

AbbVie Inc. (ABBV) (Biopharmaceutical company: immunology, kidney disease, liver disease, neuroscience, oncology, women’s health)

Abeona Therapeutics (ABEO) (Gene therapy and plasma-based products)

AC Immune SA (ACIU) (IPO September 23: biopharmaceutical company focused on diseases that are associated with protein misfolding)

ACADIA Pharmaceuticals Inc. (ACAD) (Biopharmaceutical company: central nervous system disorders)

Acasti Pharma, Inc. (ACST) (Canada, biopharmaceutical company: active pharmaceutical ingredients (API) for the management of cardiometabolic disorders)

Acceleron Pharma Inc. (XLRN) (Cancer and orphan diseases)

Achaogen, Inc. (AKAO) (Biopharmaceutical company: antibacterials to treat multi-drug resistant gram-negative infections)

Achillion Pharmaceuticals, Inc. (ACHN) (Complement-related diseases and infectious diseases)

Acorda Therapeutics, Inc. (ACOR) (Biopharmaceutical company: neurological disorders)

Actinium Pharmaceuticals, Inc. (ATNM) (Biopharmaceutical company: immunotherapeutics for the treatment of advanced cancers)

Adaptimmune Therapeutics plc (ADAP) (IPO in May 2015, United Kingdom, biopharmaceutical company: cancer immunotherapy products)

ADMA Biologics Inc. (ADMA) (Biopharmaceutical company: Plasma-based biologics for the treatment and prevention of certain infectious diseases)

Aduro BioTech, Inc. (ADRO) (IPO in April 2015: Cancer immunotherapy; pancreatic cancer)

Advaxis, Inc. (ADXS) (Clinical-stage biotechnology company: immunotherapies to treat cancer)

Adverum Biotechnologies, Inc. (ADVM) (Biopharmaceutical company: serious eye diseases)

Aeglea BioTherapeutics, Inc. (AGLE) (IPO April 7, 2016: Biotech company focused therapeutics for the treatment of inborn errors of metabolism (IEM) and cancer)

AEterna Zentaris Inc. (AEZS) (Canada, biopharmaceutical company: oncology, endocrinology and women’s health)

Affimed N.V. (AFMD) (Germany, biopharmaceutical company: cancer immunotherapies)

Agenus Inc. (AGEN) (Immunology: cancer, infectious diseases)

Agios Pharmaceuticals, Inc. (AGIO) (Biopharmaceutical company: cancer and rare genetic disorders of metabolism)

Aimmune Therapeutics, Inc. (AIMT) (IPO in August 2015: Biopharmaceutical company: allergies)

Akari Therapeutics, Plc (AKTX) (United Kingdom, biopharmaceutical company: therapeutics to treat orphan autoimmune and inflammatory diseases)

Akebia Therapeutics, Inc. (AKBA) (Biopharmaceutical company: anemia secondary to chronic kidney disease)

Alcobra Ltd. (ADHD) (Israel, biopharmaceutical company: Attention Deficit Hyperactivity Disorder (ADHD) and other cognitive disorders)

Alder BioPharmaceuticals, Inc. (ALDR) (Biopharmaceutical company: migraine, autoimmune diseases and inflammatory diseases)

Aldeyra Therapeutics, Inc. (ALDX) (Treatments for diseases thought to be related to endogenous free aldehydes)

Alexion Pharmaceuticals, Inc. (ALXN) (Biopharmaceutical company: nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, hypophosphatasia, Lysosomal Acid Lipase Deficiency)

Alkermes Plc. (ALKS) (Ireland, biopharmaceutical company: medicines for the treatment of central nervous system diseases)

Alnylam Pharmaceuticals, Inc. (ALNY) (Biopharmaceutical company: RNAi therapeutics as genetic medicines; serious, life-threatening diseases)

Amarin Corporation Plc. (AMRN) (Ireland, biopharmaceutical company: cardiovascular health)

Amgen Inc. (AMGN) (Therapeutics: cardiovascular, inflammation, oncology, biosimilars)

Amicus Therapeutics, Inc. (FOLD) (Biopharmaceutical company: lysosomal storage diseases)

Ampio Pharmaceuticals, Inc. (AMPE) (Biopharmaceutical company: inflammatory conditions)

AmpliPhi Biosciences Corporation (APHB) (Biopharmaceutical company: bacterial infections)

Anavex Life Sciences Corp. (AVXL) (Biopharmaceutical company: Alzheimer’s, other CNS diseases; cancer)

ANI Pharmaceuticals, Inc. (ANIP) (Branded and generic prescription pharmaceuticals)

Anika Therapeutics Inc. (ANIK) (Therapeutic products for tissue protection, healing and repair; animal health, ophthalmic, joint health and orthopedic products, surgical products to treat ENT disorders, wound care products)

Anthera Pharmaceuticals, Inc. (ANTH) (Biopharmaceutical company: inflammation and autoimmune diseases)

Applied Genetic Technologies Corporation (AGTC) (Treatments for rare eye diseases caused by mutated genes)

Apricus Biosciences, Inc. (APRI) (Biopharmaceutical company: sexual health therapies, urology and rheumatology)

Aptevo Therapeutics Inc. (APVO) (Biosciences: oncology and hematology therapies)

Aptose Biosciences, Inc. (APTO) (Canada: therapeutics to treat life-threatening cancers; acute myeloid leukemia, high-risk myelodysplastic syndromes)

ARCA Biopharma, Inc. (ABIO) (Biopharmaceutical company: therapies for cardiovascular diseases)

Ardelyx, Inc. (ARDX) (Molecule therapeutics: gastrointestinal)

Arena Pharmaceuticals, Inc. (ARNA) (Biopharmaceutical company: drugs that target G protein-coupled receptors; weight management)

Argos Therapeutics, Inc. (ARGS) (Biopharmaceutical company: immunotherapies for the treatment of cancer and infectious diseases)

Ariad Pharmaceuticals, Inc. (ARIA) (Oncology company: chronic and acute leukemia, lung cancer and other difficult-to-treat cancers)

ArQule, Inc. (ARQL) (Small molecule cancer therapeutics)

Array BioPharma Inc. (ARRY) (Biopharmaceutical company: targeted small molecule drugs used to treat patients afflicted with cancer)

Arrowhead Research Corporation (ARWR) (Biopharmaceutical company: RNAi therapeutics, chronic hepatitis B infection)

Arbutus Biopharma Corporation (ABUS) (Canada, biopharmaceutical company: chronic hepatitis B infection)

Ascendis Pharma (ASND) (IPO in January 2015: Denmark, biopharmaceutical company: growth hormone deficiency, pulmonary arterial hypertension)

Assembly Biosciences, Inc. (ASMB) (Biopharmaceutical company: treatments for hepatitis B virus infection and C. difficile-associated diarrhea)

Asterias Biotherapeutics, Inc. (AST) (Regenerative medicine: therapeutics developed from platforms based on pluripotent stem cells and dendritic cell cancer immunotherapy)

AstraZeneca Plc. (AZN) (United Kingdom, biopharmaceutical company: autoimmune, cardiovascular, infection, inflammation, metabolic, neuroscience, oncology, respiratory)

Atara Biotherapeutics, Inc. (ATRA) (Molecularly-targeted product candidates and T-cell product candidates; cancer, kidney disease and other illnesses)

Athersys, Inc. (ATHX) (Biopharmaceutical company: most advanced programs in area of regenerative medicine; stem cell products)

aTyr Pharma Inc. (LIFE) (IPO in May 2015: Medicines used in the treatment of severe rare diseases)

Audentes Therapeutics, Inc. (BOLD) (IPO July 20, 2016: biotech company focused on therapy treatments for rare diseases)

Aurinia Pharmaceuticals Inc. (AUPH) (Canada, biopharmaceutical company: lupus nephritis)

Auris Medical Holding AG (EARS) (Switzerland: inner ear therapies)

AVEO Pharmaceuticals, Inc. (AVEO) (Biopharmaceutical company: therapies through biomarker-driven insights)

Avexis Inc. (AVXS) (IPO February 11, 2016: Gene therapy company with a focus on rare neurological genetic diseases)

Aviragen Therapeutics, Inc. (AVIR) (Antivirals to treat infections)

Axovant Sciences Ltd. (AXON) (Therapeutics designed to treat dementia)

Axsome Therapeutics, Inc. (AXSM) (IPO in November 2015: Biopharmaceutical company: therapies for pan management and central nervous system disorders)

AzurRx BioPharma, Inc. (AZRX) (IPO October 11, 2016: Development stage biopharmaceutical company focused on gastrointestinal disorders)

Beigene, Ltd. (BGNE) (IPO February 3, 2016: Biopharmaceutical company with therapeutics designed to treat cancer)

Bellerophon Therapeutics, Inc. (BLPH) (Cardiopulmonary and cardiac diseases)

Bellicum Pharmaceuticals, Inc. (BLCM) (Biopharmaceutical company: cellular immunotherapies for various forms of cancer; hematological and solid tumors, orphan inherited blood disorders)

Benitec Biopharma LTD (BNTC) (IPO in August 2015: Australia, biopharmaceutical company: gene silencing technology)

Bio Blast Pharma Ltd. (ORPN) (Therapies for patients with rare and ultra-rare genetic diseases)

BioCryst Pharmaceuticals, Inc. (BCRX) (Infectious and inflammatory diseases)

Biogen Inc. (BIIB) (Biopharmaceutical company: therapies for immunology, hematology, multiple sclerosis, neurology)

BioLife Solutions, Inc. (BLFS) (Hypothermic storage and cryopreservation products; thermal shipping products for cells, tissues, and organs)

BioLineRx Ltd. (BLRX) (Israel, biopharmaceutical company: Cardiac device, acute myeloid leukemia, celiac disease, infectious diseases, inflammatory bowel disease, skin lesions)

BioMarin Pharmaceutical Inc. (BMRN) (Therapies for serious and life-threatening rare and ultra-rare genetic diseases)

BiondVax Pharmaceuticals Ltd. (BVXV) (IPO in May 2015: Israel, biopharmaceutical company: flu vaccine)

Bio-Path Holdings, Inc. (BPTH) (Therapeutic products utilizing its proprietary liposomal delivery technology; blood cancer, triple negative and inflammatory breast cancers)

BioSpecifics Technologies Corp (BSTC) (Biopharmaceutical company: injectable collagenase used for treatment of Dupuytren’s contracture and Peyronie’s disease)

Biostage, Inc. (BSTG) (Bioengineered organ implants)

Bio-Techne Corp (TECH) (Bioactive tools and resources used in the research and clinical diagnostic markets)

BioTime, Inc. (BTX) (Regenerative medicine to patients with serious diseases and degenerative conditions)

Bluebird Bio, Inc. (BLUE) (Gene therapy)

Blueprint Medicines Corporation (BPMC) (IPO in April 2015: Biopharmaceutical company: kinase inhibitors for genomically defined cancers)

Brainstorm Cell Therapeutics Inc. (BCLI) (Stem cell therapies for neurodegenerative diseases)

Bristol-Myers Squibb Company (BMY) (Biopharmaceutical company: cancer, cardiovascular disease, hepatitis B and hepatitis C, HIV/AIDS, rheumatoid arthritis)

Caladrius Biosciences, Inc. (CLBS) (Immunotherapy company: cell process optimization, development, and manufacturing)

Calithera Biosciences, Inc. (CALA) (Immunotherapy company: cell process optimization, development, and manufacturing)

Can-Fite Biopharma Ltd (CANF) (Israel: biopharmaceutical company: autoimmune-inflammatory and cancer diseases)

Capricor Therapeutics, Inc. (CAPR) (Treatment of heart failure and heart attacks)

Cara Therapeutics, Inc. (CARA) (Chemical entities designed to alleviate pain and pruritus)

Cascadian Therapeutics Inc. (CASC) (Biopharmaceutical company: cancer treatments)

CASI Pharmaceuticals, Inc. (CASI) (Biopharmaceutical company: therapeutics addressing cancer and other unmet medical needs; focus on China)

Catabasis Pharmaceuticals Inc. (CATB) (Biopharmaceutical company: rare diseases, serious lipid disorders)

Catalyst Biosciences, Inc. (CBIO) (Biopharmaceutical company: hemostasis)

Catalyst Pharmaceutical Partners, Inc. (CPRX) (Biopharmaceutical company: rare neuromuscular and neurological diseases)

Celgene Corporation (CELG) (Biopharmaceutical company: cancer and immune-inflammatory related diseases)

Cellect Biotechnology Ltd. (APOP) (IPO July 29, 2016: biotech company with functional stem cells selection platform)

Cellectis SA (CLLS) (IPO in March 2015, France: Gene-editing company; cancer therapies based on engineered T cells)

Celldex Therapeutics, Inc. (CLDX) (Therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines; brain cancer, triple negative breast cancer)

Cellectar Biosciences, Inc. (CLRB) (Agents to detect, treat and monitor a broad spectrum of cancers)

Cellular Biomedicine Group, Inc. (CBMG) (Treatments for degenerative and cancerous diseases)

Cel-Sci Corporation (CVM) (Immunotherapy products for the treatment of cancer and infectious diseases)

Celsion Corporation (CLSN) (Oncology company: chemotherapies, immunotherapies and RNA- or DNA-based therapies)

Celyad SA (CYAD) (IPO in June 2015, Belgium: Cell therapy treatments; cardiovascular disease, oncology)

Cerecor Inc. (CERCU) (IPO in October 2015: Biopharmaceutical company: neurological and psychiatric diseases)

Cerulean Pharma Inc. (CERU) (NDCs designed to selectively attack tumor cells and reduce toxicity)

Cerus Corporation (CERS) (Biomedical products company: blood safety)

Cesca Therapeutics Inc. (KOOL) (Cell-based therapeutics for use in regenerative medicine)

Champions Oncology, Inc. (CSBR) (Solutions and services designed to personalize the development and use of oncology drugs)

ChemoCentryx, Inc. (CCXI) (Biopharmaceutical company: orally-administered therapeutics for the treatment of autoimmune diseases, inflammatory disorders and cancer)

Chiasma Inc. (CHMA) (IPO in July 2015, biopharmaceutical company: oral versions of injected drugs for orphan diseases)

Chimerix, Inc. (CMRX) (Biopharmaceutical company: oral antivirals)

China Biologic Products, Inc. (CBPO) (China: plasma-based biopharmaceutical company)

China Pharma Holdings, Inc. (CPHI) (China, biopharmaceutical company: main focus for its therapeutics includes CNS, cardiovascular, cerebrovascular, wound recovery, digestive disease and infectious diseases)

Cidara Therapeutics, Inc. (CDTX) (IPO in April 2015: Anti-infectives; fungal infections)

Clearside Biomedical, Inc. (CLSD) (IPO June 2, 2016: biopharmaceutical company focused on therapies for blinding eye diseases)

Cleveland BioLabs, Inc. (CBLI) (Biopharmaceutical company: toll-like immune receptor activators; applications in radiation mitigation, oncology immunotherapy and vaccines)

Clovis Oncology, Inc. (CLVS) (Biopharmaceutical company: cancer treatments; non-small cell lung cancer, ovarian cancer, pancreatic cancer, breast and lung cancers)

Codexis, Inc. (CDXS) (Protein engineering company: develops biocatalysts for pharmaceuticals and fine chemicals markets)

Coherus BioSciences, Inc. (CHRS) (Biosimilar pure play)

CoLucid Pharmaceuticals, Inc. (CLCD) (Biopharmaceutical company: treatment of migraines)

Compugen Ltd. (CGEN) (Israel: immuno-oncology programs which are aimed at harnessing the immune system to eradicate cancer)

Conatus Pharmaceuticals Inc. (CNAT) (Medicines to treat liver disease)

Concert Pharmaceuticals, Inc. (CNCE) (CNS disorders, renal disease, inflammation and cancer)

ContraFect Corporation (CFRX) (Therapeutic protein and antibody products for infectious diseases)

Corbus Pharmaceuticals Holdings, Inc. (CRBP) (Biopharmaceutical company: rare, life-threatening, inflammatory diseases)

CorMedix Inc. (CRMD) (Biopharmaceutical company: cardiac, renal and infectious diseases)

Corvus Pharmaceuticals, Inc. (CRVS) (IPO March 23, 2016: Biopharmaceutical company focused on immuno-oncology therapies for cancer)

CTI BioPharma Corp. (CTIC) (Biopharmaceutical company: therapies covering a spectrum of blood-related cancers)

Curis, Inc. (CRIS) (Drug candidates for the treatment of human cancers)

Cyclacel Pharmaceuticals, Inc. (CYCC) (Biopharmaceutical company: oral therapies used in the treatment of cancer and other serious diseases)

Cymabay Therapeutics Inc. (CBAY) (Biopharmaceutical company: metabolic diseases)

Cytokinetics, Incorporated (CYTK) (Biopharmaceutical company: debilitating diseases in which muscle performance is compromised and/or declining)

CytomX Therapeutics Inc. (CTMX) (IPO in October 2015: Biopharmaceutical company; antibody therapeutics, oncology)

Cytori Therapeutics Inc. (CYTX) (Clinical stage company: cell therapies to treat cardiovascular disease and repair soft tissue defects)

CytRx Corporation (CYTR) (Biopharmaceutical company: research and development company specializing in oncology)

DBV Technologies S.A. (DBVT) (France: therapies for food and pediatric allergy patient)

DelMar Pharmaceuticals, Inc. (DMPI) (Biopharmaceutical company focused on cancer therapies)

Dermira, Inc. (DERM) (Biopharmaceutical company: products for dermatologists and their patients)

Dicerna Pharmaceuticals, Inc. (DRNA) (Biopharmaceutical company: inherited diseases of the liver and genetically defined cancers)

Dimension Therapeutics Inc. (DMTX) (IPO in October 2015: Gene therapy platform company: rare diseases associated with the liver)

Durect Corporation (DRRX) (Biopharmaceutical company: pain management, CNS disorders, acute organ injury and metabolic diseases)

Dynavax Technologies Corporation (DVAX) (Biopharmaceutical company; products to prevent and treat infectious diseases)

Edge Therapeutics Inc. (EDGE) (IPO in October 2015: Neurological conditions)

Editas Medicine, Inc. (EDIT) (IPO February 3, 2016: Genome editing company)

Eiger BioPharmaceuticals, Inc. (EIGR) (Biopharmaceutical company: Hepatitis Delta, Hypoglycemia, Pulmonary Arterial Hypertension, Lymphedema)

Eleven Biotherapeutics, Inc. (EBIO) (Ocular therapeutics to treat patients suffering from eye diseases)

Emergent Biosolutions, Inc. (EBS) (Biopharmaceutical company: therapeutics and vaccines in hematology/oncology; transplantation and infectious disease; biological defense products)

Enanta Pharmaceuticals, Inc. (ENTA) (Small molecule drugs for viral infections and liver diseases)

Endocyte, Inc. (ECYT) (Biopharmaceutical company: therapies for the treatment of cancer and inflammatory diseases)

Enzymotec Ltd. (ENZY) (Israel: lipid-based products used in infant formula, nutritional supplements, medical disorders and diseases)

Epizyme, Inc. (EPZM) (Biopharmaceutical company: therapeutics for patients with genetically defined cancers)

Exelixis, Inc. (EXEL) (Biopharmaceutical company: small molecule therapies used in the treatment of cancer)

Fate Therapeutics, Inc. (FATE) (Biopharmaceutical company: cellular immunotherapeutics; cancer, rare genetic diseases and immune disorders)

Fibrocell Science Inc. (FCSC) (Cell and gene therapy company: rare and serious skin and connective tissue diseases)

FibroGen, Inc. (FGEN) (Biopharmaceutical company: anemia in chronic kidney disease, liver fibrosis, pancreatic cancer, corneal blindness)

Five Prime Therapeutics, Inc. (FPRX) (Protein therapeutics)

Flex Pharma, Inc. (FLKS) (Neuromuscular disorders including muscle cramps)

Fortress Biotech (FBIO) (Biopharmaceutical company: cancer, additional products in pipeline)

Forward Pharma (FWP) (Denmark: immunomodulatory compound dimethyl fumarate and derivatives used to treat immune disorders including multiple sclerosis and psoriasis)

Galapagos NV (GLPG) (IPO in May 2015: Belgium: small molecule medicines; rheumatoid arthritis)

Galectin Therapeutics Inc. (GALT) (Therapies for fibrotic diseases and cancer)

Galena Biopharma, Inc. (GALE) (Biopharmaceutical company: oncology therapeutics across the full spectrum of cancer care)

Galmed Pharmaceuticals Ltd. (GLMD) (Israel, biopharmaceutical company: oral therapy for treating liver diseases and cholesterol gallstones)

Gemphire Therapeutics Inc. (GEMP) (IPO August 5, 2016: biopharmaceutical company focused on therapies to treat dyslipidemia)

Genocea Biosciences, Inc. (GNCA) (Vaccines and immunotherapies: infectious diseases, cancers and autoimmune diseases)

GenVec, Inc. (GNVC) (Biopharmaceutical company: therapeutics and vaccines; treatments for hearing loss and balance disorders)

Geron Corporation (GERN) (Biopharmaceutical company: telomerase inhibitor in hematologic myeloid malignancies)

Gilead Sciences, Inc. (GILD) (Biopharmaceutical company: cardiovascular, human immunodeficiency virus (HIV), liver diseases, oncology and inflammation, respiratory)

Global Blood Therapeutics Inc. (GBT) (Therapeutics for patients with grievous blood-based disorders)

GlycoMimetics, Inc. (GLYC) (Vaso-occlusive crisis of sickle cell disease; treatment for AML in combination with chemotherapy)

Grifols, S.A. (GRFS) (Spain: Bioscience (treatment of medical conditions using blood or blood components), diagnostics, hospital (intravenous therapy products, clinical nutrition products, sterile products and medical devices), plasma derivatives)

GTX, Inc. (GTXI) (Small molecules for the treatment of cancer and serious medical conditions)

Halozyme Therapeutics, Inc. (HALO) (Oncology therapies that target the tumor microenvironment)

Heat Biologics, Inc. (HTBX) (Therapeutic vaccines to combat a wide range of cancers and infectious diseases)

Hemispherx BioPharma, Inc. (HEB) (Biopharmaceutical company: drug entities used in the treatment of viral and immune-based disorders)

Horizon Pharma plc (HZNP) (Ireland, biopharmaceutical company: arthritis pain, rare diseases)

Hutchison China MediTech Limited (HCM) (IPO March 17, 2016: Biopharmaceutical company focused on immunological diseases and oncology in addition to consumer health products)

iBio, Inc. (IBIO) (Develops pharmaceutical product applications through its iBioLaunch platform)

Idera Pharmaceuticals, Inc. (IDRA) (B-cell Lymphoma, autoimmune, rare)

IDEXX Laboratories, Inc. (IDXX) (Diagnostic and information technology-based solutions)

Ignyta, Inc. (RXDX) (Oncology company)

ImmuCell Corporation (ICCC) (Biotechnology company focused on improving animal health and productivity in the dairy and beef industries)

Immune Design Corp. (IMDZ) (Immunotherapy company)

ImmunoCellular Therapeutics, Ltd. (IMUC) (Immune-based therapies for the treatment of brain cancers and other cancers)

ImmunoGen, Inc. (IMGN) (Tumor-targeting antibodies to deliver a cell-killing agent specifically to cancer cells)

Immunomedics, Inc. (IMMU) (Biopharmaceutical company: antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases)

Imprimis Pharmaceuticals, Inc. (IMMY) (Ophthalmology and urology drug therapies)

Incyte Corporation (INCY) (Biopharmaceutical company: small molecule drugs; oncology and inflammation)

Infinity Pharmaceuticals, Inc. (INFI) (Biopharmaceutical company: Blood cancers, indolent non-Hodgkin lymphoma, chronic lymphocytic leukemia)

Inotek Pharmaceuticals Corporation (ITEK) (Biopharmaceutical company: therapies to treat glaucoma and other serious diseases of the eye)

Innoviva, Inc. (INVA) (Royalty: bio-pharmaceuticals, respiratory assets)

Inovio Pharmaceuticals, Inc. (INO) (Cancer, infectious diseases, vaccines)

Insmed, Inc. (INSM) (Biopharmaceutical company: lung disease and pulmonary arterial hypertension)

Intec Pharma Ltd. (NTEC) (IPO in August 2015: Israel, biopharmaceutical company: oral drug delivery system, Parkinson’s disease)

Intellia Therapeutics, Inc. (NTLA) (IPO May 6, 2016: gene editing company)

Intercept Pharmaceuticals, Inc. (ICPT) (Biopharmaceutical company: orphan and more prevalent liver diseases)

Intra-Cellular Therapies Inc. (ITCI) (Biopharmaceutical company: drugs for the treatment of diseases and disorders of the Central Nervous System)

Intrexon Corporation (XON) (Products for the consumer, energy, food, health and environmental industries)

Ionis Pharmaceuticals, Inc. (IONS) (RNA-targeted drug discovery and development: cancer, cardiovascular, metabolic, neurological disorders, rare diseases)

Jaguar Animal Health (JAGX) (IPO in May 2015: Animal health: gastrointestinal products)

Jazz Pharmaceuticals Plc. (JAZZ) (Ireland, biopharmaceutical company: narcolepsy, lymphoblastic leukemia, hepatic veno-occlusive disease)

Juno Therapeutics, Inc. (JUNO) (Cell-based cancer immunotherapies)

Kadmon Holdings, Inc. (KDMN) (IPO July 27, 2016: biopharmaceutical company developing product candidates within autoimmune and fibrotic diseases, oncology and genetic diseases)    

Kamada Ltd. (KMDA) (Israel, biopharmaceutical company: specialty therapeutics developed through a protein purification technology)

Keryx Biopharmaceuticals, Inc. (KERX) (Biopharmaceutical company: renal disease)

Kindred Biosciences, Inc. (KIN) (Biotechnology company that develops medicines for pets)

Kite Pharma, Inc. (KITE) (Biopharmaceutical company: cancer immunotherapy products)

Kitov Pharamceuticals Holdings Ltd. (KTOV) (Israel: anti-inflammatory drugs that treat pain without raising blood pressure)

Kura Oncology, Inc. (KURA) (IPO in November 2015: Biopharmaceutical company; therapeutics for the treatment of solid tumors and blood cancers)

La Jolla Pharmaceutical Company (LJPC) (Biopharmaceutical company: therapies for patients suffering from life-threatening diseases)

Lexicon Pharmaceuticals, Inc. (LXRX) (Biopharmaceutical company: treatment of type 1 and type 2 diabetes, treatment of carcinoid syndrome)

Ligand Pharmaceuticals Incorporated (LGND) (Biopharmaceutical company: licensing, royalty-generating assets)

Lion Biotechnologies, Inc. (LBIO) (Immunotherapies based on tumor infiltrating lymphocytes)

Loxo Oncology, Inc. (LOXO) (Cancer therapies)

Lpath, Inc. (LPTN) (Monoclonal antibodies that target bioactive lipids)

MabVax Therapeutics Holdings, Inc. (MBVX) (Monoclonal antibody-based therapeutics and vaccines for cancer)

Macrocure Ltd (MCUR) (Biopharmaceutical company: chronic and hard-to-heal wounds)

MacroGenics, Inc. (MGNX) (Biopharmaceutical company: monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases)

Mallinckrodt Plc. (MNK) (Ireland, biopharmaceutical company: ADHD, autoimmune, central nervous system disorders, pain, rare diseases; medical imaging: contrast media and delivery systems, radiopharmaceuticals)

MannKind Corporation (MNKD) (Biopharmaceutical company: therapeutic products for diseases which include diabetes)

Marinus Pharmaceuticals, Inc. (MRNS) (Biopharmaceutical company: neuropsychiatric therapeutics)

Mast Therapeutics, Inc. (MSTX) (Biopharmaceutical company: diseases and conditions typically characterized by impaired microvascular blood flow and damaged cell membranes)

Mateon Therapeutics, Inc. (MATN) (Biopharmaceutical company: vascular disrupting agents for orphan oncology indications)

MediciNova, Inc. (MNOV) (Biopharmaceutical company: neurological disorders, treatment of acute exacerbations of asthma)

MediWound Ltd. (MDWD) (Israel, Biopharmaceutical company: severe burns, chronic and other hard-to-heal wounds)

MEI Pharma, Inc. (MEIP) (Therapies for the treatment of cancer)

Merrimack Pharmaceuticals, Inc. (MACK) (Biopharmaceutical company: cancer)

Merus N.V. (MRUS) (IPO May 19, 2016, Netherlands: immuno-oncology company)

Mesoblast Ltd. (MESO) (IPO in November 2015, Australia: regenerative medicine company; areas of focus include inflammation, cardiovascular disease and back pain)

Minerva Neurosciences, Inc. (NERV) (Biopharmaceutical company: central nervous system diseases)

Mirati Therapeutics, Inc. (MRTX) (Oncology company: genetically-targeted oncology therapeutics)

Mirna Therapeutics Inc. (MIRN) (IPO in October 2015: Biopharmaceutical company: microRNA-based oncology therapeutics)

Momenta Pharmaceuticals, Inc. (MNTA) (Therapeutics for oncology and autoimmune indications)

MyoKardia Inc. (MYOK) (IPO in October 2015: Biopharmaceutical company; therapies for serious and neglected rare cardiovascular diseases)

MYOS Corporation (MYOS) (BioTherapeutics and BioNutrition company: muscle health and function)

Myovant Sciences Ltd. (MYOV) (IPO October 27, 2016: biopharmaceutical company, women’s health and other endocrine-related disorders)

Nabriva Therapeutics AG (NBRV) (IPO in September 2015: Austria, biopharmaceutical company: anti-infectives designed to treat bacterial infections)

NanoViricides, Inc. (NNVC) (Nanotechnology-based biomimetic anti-viral medicines)

Nantkwest Inc. (NK) (IPO in June 2015: Immunotherapy company: cancer)

Nektar Therapeutics (NKTR) (Biopharmaceutical company: anti-infective, anti-viral, immunology, oncology, pain)

Neptune Technologies & Bioresources Inc. (NEPT) (Canada: omega-3 dietary supplements)

Neuralstem, Inc. (CUR) (Production of central nervous system stem cells used in the treatment of central nervous system diseases)

Neurocrine Biosciences, Inc. (NBIX) (Neurological and endocrine based diseases and disorders)

NewLink Genetics Corporation (NLNK) (Biopharmaceutical company: immunotherapy products, pancreatic cancer)

Nexvet Biopharma Plc. (NVET) (IPO in February 2015: Clinical-stage biopharmaceutical company; dogs and cats)

Northwest Biotherapeutics, Inc. (NWBO) (Cancer vaccines designed to treat a broad range of solid tumor cancers)

NovaBay Pharmaceuticals, Inc. (Biopharmaceutical company: anti-infective treatments, ophthalmology)

Novavax, Inc. (NVAX) (Vaccine company; products to prevent infectious diseases)

NovoCure Ltd. (NVCR) (IPO in October 2015, oncology company: treatment of solid tumor cancers)

Novogen Limited (NVGN) (Australia, bio-pharmaceutical company: Drug technology platforms with applications across a range of oncology indications)

Nymox Pharmaceutical Corporation (NYMX) (Drugs and diagnostic products for the aging population; treatment for enlarged prostate or benign prostatic hyperplasia)

Ocera Therapeutics, Inc. (OCRX) (Biopharmaceutical company: acute and chronic liver disease)

Ocular Therapeutix, Inc. (OCUL) (Biopharmaceutical company: therapies for diseases and conditions of the eye through its hydrogel platform technology)

Ohr Pharmaceuticals, Inc. (OHRP) (Ocular diseases)

Omeros Corporation (OMER) (Biopharmaceutical company: small-molecule and protein therapeutics targeting inflammation, coagulopathies and disorders of the central nervous system)

Oncobiologics, Inc. (ONS) (IPO May 13, 2016, biopharmaceutical company: biosimilar therapeutics)

OncoGenex Pharmaceuticals Inc. (OGXI) (Therapeutics that target mechanisms of treatment resistance in cancer)

OncoMed Pharmaceuticals, Inc. (OMED) (Biopharmaceutical company: antibody therapeutics targeting cancer stem cells)

Onconova Therapeutics, Inc. (ONTX) (Biopharmaceutical company: small molecule drug candidates used in the treatment of cancer)

OncoSec Medical Inc. (ONCS) (Technologies designed to stimulate the body’s immune system; cancer)

Opexa Therapeutics, Inc. (OPXA) (Personalized immunotherapy: multiple sclerosis, autoimmune diseases)

Ophthotech Corporation (OPHT)  (Biopharmaceutical company: back of the eye diseases)

Oragenics, Inc. (OGEN) (Biopharmaceutical company: oral probiotics products and antibiotics for humans and companion pets)

Orexigen Therapeutics, Inc. (OREX) (Biopharmaceutical company: obesity)

Organovo Holdings, Inc. (ONVO) (3D bioprinting technology)

Osiris Therapeutics, Inc. (OSIR) (Regenerative products for wound care, sports medicine, and orthopaedics)

Otonomy, Inc. (OTIC) (Biopharmaceutical company: therapeutics for the treatment of diseases and disorders of the ear)

Ovascience Inc. (OVAS) (Life sciences company: treatments for infertility)

Pacific Biosciences of California, Inc. (PACB) (Systems for gene sequencing; platform that enables real-time analysis of biomolecules with single molecule resolution)

Pain Therapeutics (PTIE) (Biopharmaceutical company; painkillers)

Palatin Technologies, Inc. (PTN) (Biopharmaceutical company: female sexual dysfunction; development programs or drug candidates for other areas)

Paratek Pharmaceuticals, Inc. (PRTK) (Antibiotics)

PDL BioPharma, Inc. (PDLI) (Patents and royalty assets: antibody humanization patents)

Peregrine Pharmaceuticals Inc. (PPHM) (Biopharmaceutical company: antibodies; treatment and diagnosis of cancer)

Pfenex Inc. (PFNX) (Non-glycosylated biosimilars)

PharmAthene, Inc. (PIP) (Biological and chemical defense products)

Phaserx, Inc. (PZRX) (IPO May, 18 2016: biopharmaceutical company focused on treatments for enzyme deficiencies in the liver)

Pieris Pharmaceuticals, Inc. (PIRS) (Biotechnology company: areas of focus include cancer, asthma and anemia)

Pluristem Therapeutics, Inc. (PSTI) (Israel: Cell therapies for a broad spectrum of diseases)

Portola Pharmaceuticals, Inc. (PTLA) (Biopharmaceutical company: thrombosis and hematological diseases)

Prana Biotechnology Ltd. (PRAN) (Australia: neurodegenerative diseases, Alzheimer’s and Huntington diseases)

Prima BioMed Ltd (PBMD) (Australia: immunotherapeutic products for the treatment of cancer)

Progenics Pharmaceuticals Inc. (PGNX) (Oncology company: diagnostic and therapeutic needs of prostate cancer patients)

ProNAi Therapeutics Inc. (DNAI) (IPO in July 2015, Canada; Oncology company: therapeutics based on their DNA interference technology platform)

ProQR Therapeutics N.V. (PRQR) (Netherlands: Cystic fibrosis and severe genetic disorders)

Protagonist Therapeutics, Inc. (PTGX) (IPO August 11, 2016: biopharmaceutical company with a platform focused on discovering and developing peptide-based new chemical entities)

Protalix BioTherapeutics, Inc. (PLX) (Israel, biopharmaceutical company: therapeutic proteins used in the treatment of genetic disorders including Gaucher disease and Fabry disease)

Prothena Corporation plc (PRTA) (Ireland: therapeutic monoclonal antibodies directed specifically to disease-causing proteins)

Proteon Therapeutics, Inc. (PRTO) (Biopharmaceutical company: kidney and vascular diseases)

Proteostasis Therapeutics, Inc. (PTI) (IPO February 11, 2016: Biopharmaceutical company with an initial focus on cystic fibrosis)

PTC Therapeutics, Inc. (PTCT) (Biopharmaceutical company: oral treatments)

Pulmatrix Inc. (PULM) (Biopharmaceutical company: therapies to address pulmonary disease)

Puma Biotechnology Inc. (PBYI) (Biopharmaceutical company: products for the treatment of various forms of cancer)

Qiagen N.V. (QGEN) (Netherlands: Sample & assay technologies: automated systems and consumable products; bioinformatics)

Ra Pharmaceuticals, Inc. (RARX) (IPO October 26, 2016:  biopharmaceutical company, therapeutics for complement-mediated diseases)

Radius Health, Inc. (RDUS) (Biopharmaceutical company: osteoporosis, endocrine-mediated diseases)

Redhill Biopharma Ltd. (RDHL) (Israel, biopharmaceutical company: inflammatory and gastrointestinal diseases, gastrointestinal cancers)

Regeneron Pharmaceuticals, Inc. (REGN) (Biopharmaceutical company: Antibody technologies; cardiovascular, diabetes, eye diseases, infectious diseases, inflammation, oncology, pain)

Regenxbio Inc. (RGNX) (IPO in September 2015: In vivo gene therapy products designed to treat various diseases)

Regulus Therapeutics Inc. (RGLS) (Biopharmaceutical company: microRNA therapeutics for oncology indications and orphan diseases)

Repros Therapeutics Inc. (RPRX) (Biopharmaceutical company: reproductive system disorders)

Retrophin, Inc. (RTRX) (Biopharmaceutical company: catastrophic diseases affecting children)

Revance Therapeutics, Inc. (RVNC) (Biopharmaceutical company: botulinum toxin products used in aesthetic and therapeutic applications)

Rexahn Pharmaceuticals, Inc. (RNN) (Biopharmaceutical company: therapeutics for the treatment of cancer)

Rigel Pharmaceuticals, Inc. (RIGL) (Small-molecule drugs for the treatment of immune diseases and cancers)

Rockwell Medical, Inc. (RMTI) (Biopharmaceutical company: end-stage renal disease and chronic kidney disease)

RXI Pharmaceuticals Corporation (RXII) (Therapeutics in the areas of dermatology and ophthalmology)

Sangamo BioSciences, Inc. (SGMO) (Biopharmaceutical company: infectious diseases, monogenic diseases, hemoglobinopathies)

Sage Therapeutics, Inc. (SAGE) (Biopharmaceutical company: rare central nervous system disorders)

Sarepta Therapeutics, Inc. (SRPT) (Biopharmaceutical company: RNA-based therapeutics; rare and infectious diseases)

Seattle Genetics, Inc. (SGEN) (Antibody-based therapies for the treatment of cancer)

Selecta Biosciences, Inc. (SELB) (IPO June 22, 2016: clinical-stage biopharmaceutical company focused on products designed to modulate the immune system)

Seres Therapeutics Inc. (MCRB) (IPO in June 2015: microbiome therapeutics platform)

Shire Plc. (SHPG) (Ireland, biopharmaceutical company: gastrointestinal, internal medicine, rare diseases, neuroscience)

Sinovac Biotech, Ltd. (SVA) (China: Biopharmaceutical company: vaccines that protect against human infectious diseases)

Sophiris Bio, Inc. (SPHS) (Biopharmaceutical company: urological diseases)

Sorrento Therapeutics, Inc. (SRNE) (Oncology company: treatments for cancer and associated pain)

Spark Therapeutics, Inc. (ONCE) (Gene therapies: treatments for debilitating genetic diseases)

Spectrum Pharmaceuticals, Inc. (SPPI) (Hematology, oncology)

Stellar Biotechnologies, Inc. (SBOT) (Immunotherapy)

Stemline Therapeutics, Inc. (STML) (Biopharmaceutical company: therapeutics that target cancer stem cells and tumor bulk)

Strongbridge Biopharma plc (SBBP) (IPO in October 2015: Biopharmaceutical company; rare endocrine disorders and other rare diseases)

Sucampo Pharmaceuticals, Inc. (SCMP) (Biopharmaceutical company: drug approved for the treatment of CIC in adults and OIC in adults with chronic, non-cancer pain)

Summit Therapeutics Plc. (SMMT) (IPO in March 2015: United Kingdom, biopharmaceutical company: Duchenne Muscular Dystrophy, infectious disease caused by the bacteria C. difficile)

Sunesis Pharmaceuticals, Inc. (SNSS) (Biopharmaceutical company: oncology therapeutics for the potential treatment of solid and hematologic cancers)

Syndax Pharmaceuticals, Inc. (SNDX) (IPO March 3, 2016: Biopharmaceutical company engaged in the development of cancer treatments)

Synergy Pharmaceuticals, Inc. (SGYP) (Biopharmaceutical company: therapies for the treatment of gastrointestinal diseases and disorders)

Synthetic Biologics, Inc. (SYN) (Therapeutics to protect the microbiome)

Syros Pharmaceuticals, Inc. (SYRS) (IPO June 30, 2016: Biopharmaceutical company, gene control medicines)

Tenax Therapeutics, Inc. (TENX) (Treatment for various critical care conditions)

Tesaro, Inc. (TSRO) (Biopharmaceutical company: oncology therapeutics and supportive care products)

TetraLogic Pharmaceuticals Corporation (TLOG) (Biopharmaceutical company: cancer and infectious diseases)

TG Therapeutics, Inc. (TGTX) (Biopharmaceutical company: B-cell malignancies and autoimmune diseases)

Theravance Biopharma, Inc. (TBPH) (Biopharmaceutical company: diseases of the lung, gastrointestinal tract, infectious diseases)

Threshold Pharmaceuticals, Inc. (THLD) (Therapeutic agents that selectively target tumor cells)

TiGenix NV (TIG) (IPO December 15, 2016: biopharmaceutical company, allogeneic stem cell therapies)

Titan Pharmaceuticals, Inc. (TTNP) (Biopharmaceutical company: CNS disorders)

Tokai Pharmaceuticals, Inc. (TKAI) (Therapies for cancer; prostate cancer)

Tonix Pharmaceuticals Holding Corp. (TNXP) (Medicines for common disorders of the central nervous system: fibromyalgia, post-traumatic stress disorder, episodic tension-type headache)

Tracon Pharmaceuticals, Inc. (TCON) (IPO in January 2015: Biopharmaceutical company: therapeutics for cancer, age-related macular degeneration and fibrotic diseases)

Transgenomic, Inc. (TBIO) (Diagnostic technologies; genetic tests; equipment, reagents and other consumables with applications in molecular testing and cytogenetics)

Trevena, Inc. (TRVN) (Biopharmaceutical company: discovery and development of GPCR biased ligands)

Trillium Therapeutics Inc. (TRIL) (Canada: immuno-oncology company)

Ultragenyx Pharmaceutical Inc. (RARE) (Biopharmaceutical company: debilitating genetic diseases)

UniQure N.V. (QURE) (Netherlands: gene therapy)

United Therapeutics Corporation (UTHR) (Pulmonary arterial hypertension)

Vanda Pharmaceuticals Inc. (VNDA) (Biopharmaceutical company: atopic dermatitis, Non-24-Hour Disorder, schizophrenia)

Vascular Biogenics Ltd. (VBLT) (Israel: Treatments for cancer)

VBI Vaccines Inc. (VBIV) (Biopharmaceutical company: vaccines)

Verastem, Inc. (VSTM) (Biopharmaceutical company: drugs to treat cancer by the targeted killing of cancer stem cells)

Vericel Corporation (VCEL) (Cellular therapies for treatment of severe diseases and conditions)

Versartis, Inc. (VSAR) (Biopharmaceutical company: treatment of endocrine disorders)

Vertex Pharmaceuticals Incorporated (VRTX) (Cystic fibrosis; additional ongoing research programs aimed at other serious and life-threatening diseases)

Vical Incorporated (VICL) (Biopharmaceutical company: infectious diseases through DNA delivery technologies and therapeutic approaches)

Viking Therapeutics (VKTX) (IPO in April 2015: Therapeutics for patients suffering from metabolic and endocrine disorders)

VistaGen Therapeutics, Inc. (VTGN) (Biopharmaceutical company focused on treatments for central nervous system disorders)

Vital Therapies, Inc. (VTL) (Cell-based system for the treatment of acute liver failure)

VIVUS, Inc. (VVUS) (Biopharmaceutical company: weight management, erectile dysfunction)

Voyager Therapeutics, Inc. (VYGR) (IPO in November 2015: clinical stage gene therapy company: central nervous system)

Wave Life Sciences Ltd. (WVE) (IPO in November 2015: Biopharmaceutical company; stereopure nucleic acid therapeutic candidates)

Windtree Therapeutics, Inc. (WINT) (Biotechnology company: respiratory distress syndrome in premature infants)

Xbiotech Inc. (XBIT) (IPO in April 2015, biopharmaceutical company: cancer antibodies)

Xenon Pharmaceuticals Inc. (XENE) (Canada, biopharmaceutical company: lipoprotein lipase deficiency)

Xencor, Inc. (XNCR) (Antibody therapeutics: autoimmune disorders, asthma and allergic diseases, cancer)

XOMA Corporation (XOMA) (Therapeutic antibodies; endocrine assets with the potential address multiple indications)

XTL Biopharmaceuticals Ltd. (XTLB) (Israel, biopharmaceutical company: autoimmune diseases; blood cancer)

Zafgen, Inc. (ZFGN) (Biopharmaceutical company: obesity)

Ziopharm Oncology Inc. (ZIOP)  (Biopharmaceutical company: cell-based therapies for the treatment of cancer)

Zynerba Pharmaceuticals Inc. (ZYNE) (Synthetic cannabinoid treatments)